The researchers said their one-step, inducible, multiplex gene knockdown and gene knockout platforms can be used in many differentiated cell types.
University of Cambridge researchers found that people who learned their genetic risk of developing diabetes did not have increased motivation to make lifestyle changes.
The results of this meta-analysis by University of Cambridge-led team could have implications for LDL-C-lowering therapies.
Genome sequences of individuals from populations around the world provided insights into out-of-Africa migrations and Aboriginal Australian ancestry.
Tapping data for hundreds of thousands of individuals, three teams uncovered overlaps between blood pressure and other metabolic and immune traits.
Genome sequencing on more than 100 esophageal adenocarcinoma tumors led to structural rearrangements and three esophageal adenocarcinoma mutational subtypes.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
The expression signature reflects the role of protein aggregation in disease progression.
By replacing amino acids during translation, scientists from several groups are homing in on a method to enable cell-specific proteomic analyses.
A UK research team performed single-cell RNA sequencing on epiblast cells to learn more about how gene expression directs organ formation.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.